Home Features
-
Merryman, Lindsley make headway in drug development to cure pulmonary arterial hypertension
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreSep. 13, 2023
-
Engineering alumna CJ Warner is recognized with 2023 Vanderbilt alumni award
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreSep. 13, 2023
-
Jules White offers second free ChatGPT online course; Enrollment opens today
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreSep. 13, 2023
-
NASA awards $15M to team led by Vanderbilt-initiated startup Zeno Power to support lunar exploration
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreSep. 11, 2023
-
Computer science professor helps conduct the largest archaeological imagery survey in the Western Hemisphere using AI
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreSep. 7, 2023
-
Vanderbilt researchers develop innovative plasmonic nanotweezer to more rapidly trap potentially cancerous nanosized particles
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreSep. 6, 2023
-
Vanderbilt Engineering First Week of School Photos (Gallery)
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreAug. 28, 2023
-
Institute for Software Integrated Systems celebrates 25 years of growth
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreAug. 25, 2023
-
Biomedical researcher Audrey Bowden organizes inaugural ‘Nature’ conference on bioengineering for global health, Nov. 13–15
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreAug. 24, 2023
-
Engineering doctoral students, postdoctoral researchers awarded prestigious NIH fellowships
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without… Read MoreAug. 24, 2023